4.5 Article

IL-17A promotes the progression of Alzheimer's disease in APP/PS1 mice

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

2022 Alzheimer's disease facts and figures

Joseph Gaugler et al.

Summary: This article discusses the impact of Alzheimer's disease on public health, including its incidence, prevalence, mortality and morbidity rates, healthcare costs and caregivers' burden. It also addresses the perspectives of consumers and primary care physicians on mild cognitive impairment (MCI) and the need for improved awareness, diagnosis, and treatment. The article emphasizes the increasing number of individuals living with Alzheimer's and the challenges faced by caregivers and healthcare providers, particularly during the COVID-19 pandemic.

ALZHEIMERS & DEMENTIA (2022)

Review Cell Biology

The Potential Role of Cytokines and Growth Factors in the Pathogenesis of Alzheimer's Disease

Gilbert Ogunmokun et al.

Summary: Alzheimer's disease is a prominent neurodegenerative disease that impairs cognitive function and is associated with neuroinflammation. Understanding factors such as cytokines and growth factors related to the development of AD can help us better understand and treat the disease.

CELLS (2021)

Article Biochemistry & Molecular Biology

Microglial activation and tau propagate jointly across Braak stages

Tharick A. Pascoal et al.

Summary: The study found a correlation between microglial activation and tau accumulation in patients with Alzheimer's disease, following a Braak-like pattern. The co-occurrence of A β, tau, and microglial abnormalities was identified as the strongest predictor of cognitive impairment in the study population.

NATURE MEDICINE (2021)

Article Cell Biology

IL-17 triggers the onset of cognitive and synaptic deficits in early stages of Alzheimer's disease

Helena C. Brigas et al.

Summary: The study found that in Alzheimer's disease models, there is an accumulation of interleukin 17-producing cells in the brain and meninges of female mice, which is associated with cognitive decline. Additionally, neutralization of interleukin 17 can prevent early memory and synaptic plasticity deficits, suggesting an early involvement of interleukin 17 in Alzheimer's disease pathology.

CELL REPORTS (2021)

Article Medicine, Research & Experimental

TNF-α-dependent neuronal necroptosis regulated in Alzheimer's disease by coordination of RIPK1-p62 complex with autophagic UVRAG

Chong Xu et al.

Summary: Activated neuronal necroptosis in Alzheimer's disease depends on upstream TNF-alpha/TNFR1 signaling, with p62 recruiting RIPK1 upon TNF-alpha stimulation to induce downstream RIPK1/RIPK3/MLKL cascade leading to cell death. The ectopic accumulation of p62 is caused by impaired autophagy flux mediated by UVRAG downregulation during TNF-alpha-promoted necroptosis. Overexpression of UVRAG inhibits neuronal necroptosis in both cell and mouse models of Alzheimer's disease, highlighting a potential therapeutic target.

THERANOSTICS (2021)

Article Medicine, Research & Experimental

Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease

Ethan R. Roy et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Review Geriatrics & Gerontology

Interleukin-17A: The Key Cytokine in Neurodegenerative Diseases

Junjue Chen et al.

FRONTIERS IN AGING NEUROSCIENCE (2020)

Article Clinical Neurology

The Vascular Behavioral and Cognitive Disorders criteria for vascular cognitive disorders: a validation study

P. S. Sachdev et al.

EUROPEAN JOURNAL OF NEUROLOGY (2019)

Article Immunology

Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway

Morena Zusso et al.

JOURNAL OF NEUROINFLAMMATION (2019)

Review Cell Biology

Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments

Yoo Jin Jung et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)

Review Cell Biology

Microglia in Alzheimer's disease

David V. Hansen et al.

JOURNAL OF CELL BIOLOGY (2018)

Review Neurosciences

Role of Blood-Brain Barrier in Alzheimer's Disease

Zhiyou Cai et al.

JOURNAL OF ALZHEIMERS DISEASE (2018)

Review Clinical Neurology

Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease

Boris Decourt et al.

CURRENT ALZHEIMER RESEARCH (2017)

Review Multidisciplinary Sciences

How neuroinflammation contributes to neurodegeneration

Richard M. Ransohoff

SCIENCE (2016)

Review Clinical Neurology

MDS clinical diagnostic criteria for Parkinson's disease

Ronald B. Postuma et al.

MOVEMENT DISORDERS (2015)

Review Neurosciences

Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease

Zhiyou Cai et al.

INTERNATIONAL JOURNAL OF NEUROSCIENCE (2014)

Review Pharmacology & Pharmacy

IL-17 targeted therapies for psoriasis

Andrea Chiricozzi et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)

Article Behavioral Sciences

Microglia: A new frontier for synaptic plasticity, learning and memory, and neurodegenerative disease research

Gary P. Morris et al.

NEUROBIOLOGY OF LEARNING AND MEMORY (2013)

Review Immunology

Innate IL-17-producing cells: the sentinels of the immune system

Daniel J. Cua et al.

NATURE REVIEWS IMMUNOLOGY (2010)

Article Biochemistry & Molecular Biology

Pivotal role of cerebral interleukin-17-producing γδT cells in the delayed phase of ischemic brain injury

Takashi Shichita et al.

NATURE MEDICINE (2009)

Review Medicine, General & Internal

Mild cognitive impairment

S Gauthier et al.

LANCET (2006)